XML 38 R27.htm IDEA: XBRL DOCUMENT v3.25.3
Stock-based Compensation (Tables)
9 Months Ended
Sep. 30, 2025
Stock-based Compensation [Abstract]  
Stock-Based Compensation Expense
Stock-based compensation expense was included in general and administrative and research and development costs as follows in the accompanying condensed statements of comprehensive loss for the three- and nine-month periods indicated below (in thousands):
 
 
 
Three Months
Ended
September 30,
   
Nine Months
Ended
September 30,
 
 
 
2025
   
2024
   
2025
   
2024
 
General and administrative
  $ 567    
$
549
   
$
1,810
   
$
1,850
 
Research and development
   
249
     
227
     
815
     
717
 
Total stock-based compensation
 
$
816
   
$
776
   
$
2,625
   
$
2,567
 
Stock Option Activity The following table provides a summary of stock option activity under the Company’s equity award plans:

   
Number of
Options
   
Weighted
Average
Exercise
Price
   
Weighted Average
Remaining
Contractual
Term (years)
   
Aggregate
Intrinsic
Value(1)
(in thousands)
 
 
                       
Outstanding at December 31, 2024
   
5,073,736
   
$
2.68
     
7.37
   
$
124
 
Granted
   
2,793,277
   
$
1.00
                 
Exercised
   
(30,000
)
 
$
0.90
                 
Forfeited/Cancelled
   
(618,949
)
 
$
2.07
                 
Outstanding at September 30, 2025
   
7,218,064
   
$
2.09
     
7.64
   
$
2,256
 
Vested and expected to vest at September 30, 2025
   
7,218,064
   
$
2.09
     
7.64
   
$
2,256
 
Vested and exercisable at September 30, 2025
   
3,491,162
   
$
2.75
     
5.84
   
$
506
 

(1)
The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of our common stock as of September 30, 2025 and December 31, 2024 of $1.65 and $1.19 per share, respectively.
Weighted Average Assumptions Used in Black-Scholes Option-pricing Model
The weighted average assumptions used in the Black-Scholes option pricing model are as follows during the three and nine months ended September 30, 2025 and 2024:

 
 
Three Months
Ended
September 30,
   
Nine Months
Ended
  September 30,
 
 
 
2025
   
2024
   
2025
   
2024
 
Expected stock price volatility
   
75.6
%
   
%
   
75.7
%
   
97.7
%
Expected life of options (years)
   
6.1
     
     
5.9
     
5.9
 
Expected dividend yield
   
%
   
%
   
%
   
%
Risk free interest rate
   
3.9
%
   
%
   
4.0
%
   
4.2
%
Restricted Stock Units Activity The following table summarized the Company’s RSU activity under the Company’s equity award plans:

 
 
Number of
Shares
 
Non-vested at December 31, 2024
   
1,393,230
 
Granted
   
1,655,361
 
Forfeited
   
(257,826
)
Vested
   
(381,534
)
Non-vested at September 30, 2025
   
2,409,231